X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/aikido-pharma-files-patent-application-for-the-use-of-ketamine-1626764742.pdf
https://www.prnewswire.com/news-releases/aikido-pharma-notes-advancement-in-radiopharmaceutical-research-301270638.html
https://www.prnewswire.com/news-releases/aikido-granted-sublicense-to-technology-for-targeted-psilocybin-treatment-of-neuro-inflamed-tissue-in-cancer-patients-301264075.html
https://www.prnewswire.com/news-releases/aikido-pharma-sponsors-psychedelic-compound-research-to-treat-ptsd-301257485.html
https://www.prnewswire.com/news-releases/aikido-pharma-inc-to-present-at-the-hc-wainwright-global-life-sciences-conference-virtual-event-301237346.html
https://www.prnewswire.com/news-releases/aikido-pharma-provides-update-on-its-antiviral-platform-including-the-virus-that-causes-covid-19-301231899.html
https://www.prnewswire.com/news-releases/aikido-pharma-enters-into-letter-of-intent-with-silo-pharma-for-use-of-psilocybin-and-peptide-therapy-for-cancer-treatment-301228585.html
https://www.prnewswire.com/news-releases/aikido-pharma-inc-regains-compliance-with-nasdaq-listing-requirements-301213309.html#:~:text=(Nasdaq%3A%20AIKI)%20(%22,listing%20on%20The%20NASDAQ%20Capital
https://www.prnewswire.com/news-releases/aikido-pharma-inc-executes-licensing-agreement-for-psilocybin-for-cancer-applications-301201491.html
https://www.prnewswire.com/news-releases/aikido-pharma-inc-provides-update-on-its-next-generation-chemotherapeutic-treatment-dha-dfdc-301162021.html
Market Place
Share 
